(Q54428439)

29 May 2018

title

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients. (English)

1 reference

29 May 2018

non-small-cell lung carcinoma

1 reference

1 reference

1 reference

Caicun Zhou

1

1 reference

29 May 2018

Shengxiang Ren

2

1 reference

29 May 2018

Songwen Zhou

3

1 reference

29 May 2018

Ling Zhang

4

1 reference

29 May 2018

Cunxia Su

5

1 reference

29 May 2018

Zengli Zhang

6

1 reference

29 May 2018

Qinfang Deng

7

1 reference

29 May 2018

Jie Zhang

8

1 reference

29 May 2018

publication date

12 May 2010

1 reference

29 May 2018

Japanese Journal of Clinical Oncology

published in

1 reference

29 May 2018

volume

40

1 reference

29 May 2018

issue

10

1 reference

29 May 2018

page(s)

954-960

1 reference

29 May 2018

Recent progress in carcinogenesis, progression and therapy of lung cancer: the 19th Hiroshima Cancer Seminar: the 3rd Three Universities' Consortium International Symposium, November 2009.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Identification of single nucleotide polymorphisms in human DNA repair genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ071

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYQ071

1 reference

29 May 2018

1 reference

29 May 2018